𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Remission of the lambert-eaton syndrome and small cell anaplastic carcinoma of the lung induced by chemotherapy and radiotherapy

✍ Scribed by Lawrence R. Jenkyn; Philip L. Brooks; R. Jackson Forcier; L. Herbert Maurer; José Ochoa

Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
554 KB
Volume
46
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination radiotherapy and chemotherap
Combination radiotherapy and chemotherapy for small cell carcinoma of the lung
✍ Goldberg, R. S. ;Joss, R. A. ;Bedwinek, J. ;Yates, J. W. ;Krakoff, I. H. 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB

Twenty previously untreated patients with small cell carcinoma of the lung were treated with cyclophosphamide, 400 mg/m2 and Adriamycin, 40 mg/m2 IV on day 1, followed by cytosine arabinoside, 20 mg/m2, every 12 hours subcutaneously on days 5--9; this regimen was repeated every 28 days. On days 14--

Lambert–Eaton syndrome with large-cell n
Lambert–Eaton syndrome with large-cell neuroendocrine carcinoma of the lung
✍ Christian Grommes; David C. Preston; Zaid Al-Kadhimi; Amer Alshekhlee 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB

## Abstract Lambert–Eaton syndrome (LES) is an immune‐mediated disorder of the presynaptic neuromuscular junction due to the blocking effect of the voltage‐gated calcium channel (VGCC) antibodies. Small‐cell lung cancer (SCLC) is the most common cause of LES. We report an unusual case of LES associ

Alternating non-cross-resistant combinat
Alternating non-cross-resistant combination chemotherapy for small cell anaplastic carcinoma of the lung
✍ R. S. Aroney; D. R. Bell; W. K. Chan; D. N. Dalley; J. A. Levi 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

The development of drug resistance limits the survival or patients with small cell anaplastic carcinoma of the lung (SCLC). The present study was undertaken to overcome this problem by administering two alternating noncross resistant combination chemotherapy regimens. One-hundred-one patients were e